A model for optimization of biomarker testing frequency to minimize disease and cost : example of beryllium sensitization testing
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Value |
|---|---|---|---|
| LDR | 00000nab a2200000 i 4500 | ||
| 001 | MAP20071504937 | ||
| 003 | MAP | ||
| 005 | 20080418124433.0 | ||
| 007 | hzruuu---uuuu | ||
| 008 | 040218e20031201usa|||| | |00010|eng d | ||
| 040 | $aMAP$bspa | ||
| 084 | $a872 | ||
| 245 | 1 | 0 | $aA model for optimization of biomarker testing frequency to minimize disease and cost$b: example of beryllium sensitization testing$cNancy L. Judd ... [et al.] |
| 520 | 8 | $aA common problem with medical surveillance programs using biomarkers is determining the optimal frequency of testing to minimize adverse health effects and cost. In the case of beryllium-exposed workers, frequency of testing for beryllium sensitization may be especially important. Recent studies indicate a lack of dose response for beryllium sensitization, but do support a dose response for the development of chronic beryllium disease | |
| 650 | 1 | 1 | $0MAPA20080613617$aContaminantes biológicos |
| 650 | 1 | 1 | $0MAPA20080587635$aRiesgos biológicos |
| 650 | 1 | 1 | $0MAPA20080601232$aEnfermedades crónicas |
| 650 | 0 | 1 | $0MAPA20080588953$aAnálisis de riesgos |
| 650 | 1 | 1 | $0MAPA20080543129$aBerilio |
| 650 | 0 | 1 | $0MAPA20080576615$aMedicina laboral |
| 650 | 1 | 1 | $0MAPA20080585266$aFactores de riesgo |
| 650 | 1 | 1 | $0MAPA20080553111$aAleaciones |
| 650 | 1 | 1 | $0MAPA20080571566$aCasos prácticos |
| 650 | 1 | 1 | $0MAPA20080585679$aHigiene industrial |
| 700 | 1 | $0MAPA20080103750$aJudd, Nancy L. | |
| 773 | 0 | $wMAP20077000345$tRisk analysis : an international journal$dNew York and London : Society for Risk Analysis$gVol. 23, nº 6, December, 2003 ; p. 1211-1220 |